关于Certara
Certara 利用生物模拟软件、技术和服务加速药物研发,从而改变传统的药物研发方式。其客户包括超 2,600 家生物制药公司、学术机构和来自 70 个国家的监管机构。Visit us at www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]
媒体联系人:
Alyssa Horowitz
[email protected]
Home / Press Release / Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
Radnor, Pa. — 2026 年 4 月 9 日 — Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first quarter of 2026 before market open on Monday, May 11th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
Certara 利用生物模拟软件、技术和服务加速药物研发,从而改变传统的药物研发方式。其客户包括超 2,600 家生物制药公司、学术机构和来自 70 个国家的监管机构。Visit us at www.certara.com.
David Deuchler
Gilmartin Group
[email protected]
Alyssa Horowitz
[email protected]
